Tailored Care for Somatoform Vertigo/Dizziness
1 other identifier
interventional
216
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate the efficacy of a manualised, multimodal group psychotherapy, based on integrative psychotherapy (IPT) and tailored to somatoform vertigo/dizziness (SVD) subgroups of mental disorders, compared to self-help groups (SHGs) in patients with SVD. The investigators hypothesise that patients who received IPT will demonstrate greater improvement concerning their vertigo-related handicap compared to patients from the SHGs. The investigators will also analyse the cost-effectiveness of experimental and control intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2015
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2014
CompletedFirst Posted
Study publicly available on registry
December 19, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedDecember 19, 2014
December 1, 2014
2.5 years
December 16, 2014
December 18, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Vertigo-related quality of life
Absolute improvement of vertigo-related quality of life on the Vertigo Handicap Questionnaire (VHQ) at 12 months after the 16-week therapy sessions from VHQ at randomisation/baseline.
Improvement at follow-up (12 months after treatment)
Secondary Outcomes (6)
Generic quality of life
Improvement at follow-up (12 months after treatment)
Severity of vertigo
Improvement at follow-up (12 months after treatment)
Depression
Improvement at follow-up (12 months after treatment)
Anxiety
Improvement at follow-up (12 months after treatment)
Somatisation
Improvement at follow-up (12 months after treatment)
- +1 more secondary outcomes
Other Outcomes (1)
Cost-effectiveness
Baseline and follow-up (12 months after treatment)
Study Arms (2)
SVD-tailored Integrative Psychotherapy (IPT)
EXPERIMENTALIPT is a short-term psychotherapy aiming to ameliorate both physical and psychosocial distress. It emanates from a multidirectional and dynamic relationship among body, mind, and environment irrespective of causality. In a multi-component approach, other elements are integrated into it, such as cognitive-behavioral and psychodynamic techniques, psychoeducation and body-oriented techniques. The IPT intervention tailored to SVD will be delivered for 16 weeks in a manualised setting with one group session per week (à 90 minutes) and one additional booster session three months after the end of the therapy. The group psychotherapy is on a 6-8:1 basis and will be conducted by a psychotherapist trained on the basis of the manual and under regular clinical supervision.
Self-help group (SHG)
ACTIVE COMPARATORThe experimental condition will be compared to moderated self-help groups without the implementation of additional therapeutic interventions. Those can be classified as low-level non-placebo control. Treatment will consist of 16 weekly moderated SHG sessions (one weekly session à 90 minutes) and one additional booster-session at three months after the end of the control intervention to be delivered on a 6-8:1 basis by a trained SHG moderator under clinical supervision.
Interventions
(see description of corresponding study arm)
Eligibility Criteria
You may qualify if:
- SVD diagnosis
- Clinically relevant SVD (VHQ sum score \> 45)
- Informed consent
You may not qualify if:
- Insufficient German language ability
- Insufficient cognitive abilities (Mini Mental State Test (MMST) ≤ 27)
- Severe and chronic comorbid somatic or mental disease (e.g., suicidality, severe depression, drug addiction)
- Current psychotherapeutic treatment
- Living \> 50 km away from Munich
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Limburg K, Radziej K, Sattel H, Henningsen P, Dieterich M, Probst T, Dale R, Lahmann C. A Randomized Controlled Trial Evaluating Integrative Psychotherapeutic Group Treatment Compared to Self-Help Groups in Functional Vertigo/Dizziness. J Clin Med. 2021 May 20;10(10):2215. doi: 10.3390/jcm10102215.
PMID: 34065517DERIVEDLahmann C, Henningsen P, Dieterich M, Radziej K, Schmid G. Tailored care for somatoform vertigo/dizziness: study protocol for a randomised controlled trial evaluating integrative group psychotherapy. J Neurol. 2015 Aug;262(8):1867-75. doi: 10.1007/s00415-015-7784-6. Epub 2015 May 23.
PMID: 26001913DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claas Lahmann, PD Dr. med.
Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technische Universitaet, Munich
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2014
First Posted
December 19, 2014
Study Start
January 1, 2015
Primary Completion
July 1, 2017
Study Completion
October 1, 2017
Last Updated
December 19, 2014
Record last verified: 2014-12